4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001209191-23-013676
Options or other derivatives
- Chief Business Officer acquired 228,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Yonehiro Grant Chief Business Officer | 2023-02-27 | Grant or award · Stock Option (Right to Buy) | +228,000 | 228,000 | D | ||
Loading xslF345X03/doc4.xml…